XML 52 R29.htm IDEA: XBRL DOCUMENT v3.19.1
Segment Information (Tables)
 9 Months Ended
Mar. 31, 2019
Segment Reporting [Abstract]  
Revenue by Reportable Segment
The following table presents revenue for each reportable segment and Corporate:
 
Three Months Ended March 31,
(in millions)
2019
 
2018
Pharmaceutical
$
31,361

 
$
29,720

Medical
3,871

 
3,916

Total segment revenue
35,232

 
33,636

Corporate (1)
(4
)
 
(3
)
Total revenue
$
35,228

 
$
33,633

 
Nine Months Ended March 31,
(in millions)
2019
 
2018
Pharmaceutical
$
96,516

 
$
89,786

Medical
11,678

 
11,684

Total segment revenue
108,194

 
101,470

Corporate (1)
(13
)
 
(10
)
Total revenue
$
108,181

 
$
101,460

(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Disaggregation of Revenue [Table Text Block]
The following table presents disaggregated revenue within our two reportable segments:
 
Three Months Ended March 31, 2019
 
Nine Months Ended March 31, 2019
(in millions)
 
 
 
Pharmaceutical distribution and specialty
$
31,146

 
$
95,888

Nuclear and Precision Health Solutions (1)
215

 
628

Pharmaceutical segment revenue
31,361

 
96,516

Medical distribution and products (2)
3,431

 
10,339

Cardinal Health At Home
440

 
1,339

Medical segment revenue
3,871

 
11,678

  Total segment revenue
35,232

 
108,194

Corporate (3)
(4
)
 
(13
)
Total revenue
$
35,228

 
$
108,181

(1)
Our Nuclear and Precision Health Solutions division was formerly referred to as our Nuclear Pharmacy Services division.
(2)
Comprised of all Medical segment businesses except for Cardinal Health At Home division.
(3)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Revenue from External Customers by Geographic Areas [Table Text Block]
The following table presents revenue by geographic area:
 
Three Months Ended March 31, 2019
 
Nine Months Ended March 31, 2019
(in millions)
 
 
 
United States
$
34,230

 
$
105,190

International
1,002

 
3,004

  Total segment revenue
35,232

 
108,194

Corporate (1)
(4
)
 
(13
)
Total revenue
$
35,228

 
$
108,181

(1)
Corporate revenue consists of the elimination of inter-segment revenue and other revenue not allocated to the segments.
Segment Profit by Reportable Segment
The following table presents segment profit by reportable segment and Corporate:
 
Three Months Ended March 31,
(in millions)
2019
 
2018
Pharmaceutical
$
536

 
$
596

Medical
155

 
199

Total segment profit
691

 
795

Corporate
(259
)
 
(249
)
Total operating earnings
$
432

 
$
546

 
Nine Months Ended March 31,
(in millions)
2019
 
2018
Pharmaceutical
$
1,388

 
$
1,576

Medical
479

 
548

Total segment profit
1,867

 
2,124

Corporate
(115
)
 
(918
)
Total operating earnings
$
1,752

 
$
1,206
Assets by Reportable Segment
The following table presents total assets for each reportable segment and Corporate at:
(in millions)
March 31,
2019
 
June 30,
2018
Pharmaceutical
$
21,426

 
$
21,421

Medical
15,548

 
16,066

Corporate
3,835

 
2,464

Total assets
$
40,809

 
$
39,951